MED13 anticorps (N-Term)
Aperçu rapide pour MED13 anticorps (N-Term) (ABIN2442626)
Antigène
Voir toutes MED13 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Affinity purification
-
Immunogène
- N-terminal region of human MED13
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.01 % Sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
-
- MED13 (Mediator Complex Subunit 13 (MED13))
-
Autre désignation
- MED13
-
Poids moléculaire
- 239 kDa
-
UniProt
- Q9UHV7
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Nuclear Hormone Receptor Binding, Regulation of Lipid Metabolism by PPARalpha
Antigène
-